litlas
Log inCreate account

Désiré Collen

Active 1972–2010

Also published as
DÉSIRÉ COLLEN
138
Papers
38,983
Citations
107
h-index
138
i10-index

Citations

Citations per year for Désiré Collen1951: 2 citations1973: 1 citations1974: 1 citations1975: 2 citations1976: 1 citations1977: 7 citations1978: 19 citations1979: 18 citations1980: 18 citations1981: 26 citations1982: 26 citations1983: 38 citations1984: 95 citations1985: 113 citations1986: 114 citations1987: 103 citations1988: 120 citations1989: 117 citations1990: 74 citations1991: 127 citations1992: 74 citations1993: 63 citations1994: 72 citations1995: 96 citations1996: 119 citations1997: 223 citations1998: 327 citations1999: 347 citations2000: 474 citations2001: 516 citations2002: 509 citations2003: 633 citations2004: 661 citations2005: 611 citations2006: 510 citations2007: 539 citations2008: 455 citations2009: 471 citations2010: 344 citations2011: 342 citations2012: 283 citations2013: 238 citations2014: 220 citations2015: 201 citations2016: 168 citations2017: 146 citations2018: 128 citations2019: 378 citations2020: 397 citations2021: 390 citations2022: 221 citations2023: 167 citations2024: 240 citations2025: 82 citations2026: 2 citations1952–1972: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,568 citing papers, 34.5% of this breakdownUnited Kingdom: 900 citing papers, 6.8% of this breakdownGermany: 864 citing papers, 6.5% of this breakdownBelgium: 696 citing papers, 5.3% of this breakdownJapan: 624 citing papers, 4.7% of this breakdownChina: 585 citing papers, 4.4% of this breakdownFrance: 553 citing papers, 4.2% of this breakdownCanada: 492 citing papers, 3.7% of this breakdownItaly: 471 citing papers, 3.6% of this breakdownNetherlands: 454 citing papers, 3.5% of this breakdownSweden: 347 citing papers, 2.6% of this breakdownAustralia: 293 citing papers, 2.2% of this breakdown
0%34.5%Other 18%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.4%
  • Medicine42.1%
  • Immunology and Microbiology4.2%
  • Neuroscience3.5%
  • Engineering0.7%
  • Nursing0.6%
  • Other1.5%

Topics

  • Angiogenesis and VEGF in Cancer6.6%
  • Cancer, Hypoxia, and Metabolism4.6%
  • Protease and Inhibitor Mechanisms4.4%
  • Blood Coagulation and Thrombosis Mechanisms4%
  • Cell Adhesion Molecules Research1.9%
  • Blood properties and coagulation1.5%
  • Other77%

Coauthors

All papers

Open in search
  1. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

    Authors: Peter Carmeliet, Yuval Dor, Jean-Marc Herbert, Dai Fukumura, Koen Brusselmans, Mieke Dewerchin, Michal Neeman, Françoise Bono, Rinat Abramovitch, Patrick H. Maxwell, Cameron J. Koch, Peter J. Ratcliffe, Lieve Moons, Rakesh K. Jain, Désiré Collen, Eli Keshet - Nature 1998 cited by 2,505

  2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

    Authors: Peter Carmeliet, Valérie Ferreira, Georg Breier, Saskia Pollefeyt, L Kieckens, Marina Gertsenstein, Michaela Fahrig, Ann Vandenhoeck, Kendraprasad Harpal, Carmen Eberhardt, Cathérine Declercq, Judy Pawling, Lieve Moons, Désiré Collen, Werner Risau, András Nagy - Nature 1996 cited by 4,154

  3. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

    Authors: Veerle Compernolle, Koen Brusselmans, Till Acker, Peter Hoet, Marc Tjwa, Heike Beck, Stéphane Plaisance, Yuval Dor, Eli Keshet, Florea Lupu, Benoît Nemery, Mieke Dewerchin, Paul Van Veldhoven, Karl H. Plate, Lieve Moons, Désiré Collen, Peter Carmeliet - Nature Medicine 2002 cited by 730

  4. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis

    Authors: Peter Carmeliet, Maria Grazia Lampugnani, Lieve Moons, F Breviario, Veerle Compernolle, Françoise Bono, Giovanna Balconi, Raffaella Spagnuolo, Bert Oosthuyse, Mieke Dewerchin, Adriana Zanetti, Anne Angellilo, Virginie Mattot, Dieter Nuyens, Esther Lutgens, Frédéric Clotman, M. Ruiter, Adriana Gittenberger-de Groot, Rob E. Poelmann, Florea Lupu, Jean‐Marc Herbert, Désiré Collen, Elisabetta Dejana - Cell 1999 cited by 1,287

  5. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

    Authors: Christa Maes, Peter Carmeliet, Karen Moermans, Ingrid Stockmans, Nico Smets, Désiré Collen, Roger Bouillon, Geert Carmeliet - Mechanisms of Development 2002 cited by 454

  6. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy

    Authors: Anne Angelillo‐Scherrer, Laurent Burnier, Nathalie Flores, Pierre Savi, Maria DeMol, Paul Schaeffer, Jean-Marc Herbert, Greg Lemke, Stephen P. Goff, Glenn K. Matsushima, H. Shelton Earp, Christian Vesin, Marc Hoylaerts, Stéphane Plaisance, Désiré Collen, Edward M. Conway, Bernhard Wehrle‐Haller, Peter Carmeliet - Journal of Clinical Investigation 2005 cited by 259

  7. Stromelysin‐1 (MMP‐3) is critical for intracranial bleeding after t‐PA treatment of stroke in mice

    Authors: Yasuhiro Suzuki, N. Nagai, Kazuo Umemura, Désiré Collen, H.R. Lijnen - Journal of Thrombosis and Haemostasis 2007 cited by 135

  8. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    Authors: Bert Oosthuyse, Lieve Moons, Erik Storkebaum, Heike Beck, Dieter Nuyens, Koen Brusselmans, Jo Van Dorpe, Peter W. Hellings, M. Gorselink, Stéphane Heymans, Gregor Theilmeier, Mieke Dewerchin, Vincent Laudenbach, P. Vermylen, Harold Raat, Till Acker, V. Vleminckx, Ludo Van Den Bosch, Neil R. Cashman, Hajime Fujisawa, Maarten R. Drost, Raf Sciot, Frans Bruyninckx, Daniel J. Hicklin, Can İnce, Pierre Gressèns, Florea Lupu, Karl H. Plate, Wim Robberecht, Jean‐Marc Herbert, Désiré Collen, Peter Carmeliet - Nature Genetics 2001 cited by 1,010

  9. Total inactivation of γ–secretase activity in presenilin-deficient embryonic stem cells

    Authors: An Herreman, Lutgarde Serneels, Wim Annaert, Désiré Collen, Luc Schoonjans, Bart De Strooper - Nature Cell Biology 2000 cited by 481

  10. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element

    Authors: Jan Gabriëls, M.-C. Beckers, Hao Ding, An S. De Vriese, Stéphane Plaisance, Silvère M. van der Maarel, George W. Padberg, Rune R. Frants, Jane Hewitt, Désiré Collen, Alexandra Belayew - Gene 1999 cited by 350

  11. Modulation of Adipose Tissue Expression of Murine Matrix Metalloproteinases and Their Tissue Inhibitors With Obesity

    Authors: Erik Maquoi, Carine Munaut, Alain Colige, Désiré Collen, H.R. Lijnen - Diabetes 2002 cited by 267

  12. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

    Authors: Diane Pennica, William E. Holmes, William J. Kohr, Richard N. Harkins, Gordon A. Vehar, Carole Ward, William F. Bennett, Elizabeth Yelverton, Peter H. Seeburg, Herbert L. Heyneker, David V. Goeddel, Désiré Collen - Nature 1983 cited by 1,243

  13. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

    Authors: Diether Lambrechts, Erik Storkebaum, Masafumi Morimoto, Jurgen Del‐Favero, Frederik Desmet, Stefan L. Marklund, Sabine Wyns, Vincent Thijs, Jörgen Andersson, Ingrid van Marion, Ammar Al‐Chalabi, Stéphanie Bornes, Rhiannon Musson, Valerie K. Hansen, L. Beckman, Rolf Adolfsson, Hardev Pall, Hervé Prats, Séverine Vermeire, Paul Rutgeerts, Shigehiro Katayama, Takuya Awata, Nigel Leigh, Loı̈c Lang-Lazdunski, Mieke Dewerchin, Christopher E. Shaw, Lieve Moons, Robert Vlietinck, Karen Morrison, Wim Robberecht, Christine Van Broeckhoven, Désiré Collen, Peter M. Andersen, Peter Carmeliet - Nature Genetics 2003 cited by 860

  14. Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy

    Authors: Thierry VandenDriessche, Lieven Thorrez, Abel Acosta‐Sanchez, Inge Petrus, Lili Wang, Ling Ma, Liesbeth De Waele, Yasushi Iwasaki, Veerle Gillijns, James M. Wilson, Désiré Collen, Marinee Chuah - Journal of Thrombosis and Haemostasis 2006 cited by 199

  15. Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease

    Authors: Paul Holvoet, Johan Vanhaecke, S. Janssens, Frans Van de Werf, Désiré Collen - Circulation 1998 cited by 674

  16. Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease

    Authors: Paul Holvoet, Ann Mertens, Peter Verhamme, Kris Bogaerts, Guy Beyens, Raymond Verhaeghe, Désiré Collen, Erik Muls, Frans Van de Werf - Arteriosclerosis Thrombosis and Vascular Biology 2001 cited by 527

  17. Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

    Authors: Edwin G. Bovill, Michael L. Terrin, David C. Stump, Andrew Berke, Margaret Frederick, Désiré Collen, Frederick Feit, Joel M. Gore, L. David Hillis, Costas T. Lambrew, Roy H. Leiboff, K G Mann, John E. Markis, Craig M. Pratt, Scott W. Sharkey, George Sopko, Russell P. Tracy, J H Chesebro - Annals of Internal Medicine 1991 cited by 485

  18. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

    Authors: Anne Angelillo‐Scherrer, Pablo Garcı́a de Frutos, Cristina Aparicio, Els Melis, Pierre Savi, Florea Lupu, Jef Arnout, Mieke Dewerchin, Marc Hoylaerts, Jean‐Marc Herbert, Désiré Collen, Björn Dahlbäck, Peter Carmeliet - Nature Medicine 2001 cited by 436

  19. The Plasminogen (Fibrinolytic) System

    Authors: Désiré Collen - Thrombosis and Haemostasis 1999 cited by 429

  20. Thrombomodulin-Protein C-EPCR System

    Authors: Marlies Van de Wouwer, Désiré Collen, Edward M. Conway - Arteriosclerosis Thrombosis and Vascular Biology 2004 cited by 366

  21. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

    Authors: Peter Carmeliet, L Kieckens, Luc Schoonjans, Beverly Ream, An Van Nuffelen, George C. Prendergast, Michael D. Cole, Roderick Bronson, Désiré Collen, Richard C. Mulligan - Journal of Clinical Investigation 1993 cited by 351

  22. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

    Authors: Peter Carmeliet, Lieve Moons, Roger Lijnen, Myriam Baes, Vincent Lemaı̂tre, Peter G. Tipping, Angela F. Drew, Yves Eeckhout, Steve D. Shapiro, Florea Lupu, Désiré Collen - Nature Genetics 1997 cited by 663

  23. Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice

    Authors: Victoria A. Ploplis, Peter Carmeliet, Shahrzad Vazirzadeh, Ilse Van Vlaenderen, Lieve Moons, Edward F. Plow, Désiré Collen - Circulation 1995 cited by 392

  24. Genetic evidence for a tumor suppressor role of HIF-2α

    Authors: Till Acker, Antonio Díez‐Juan, Julián Aragonés, Marc Tjwa, Koen Brusselmans, Lieve Moons, Dai Fukumura, Paz Moreno-Murciano, Jean‐Marc Herbert, Angelika M. Burger, Johanna Riedel, Gerd Elvert, Ingo Flamme, Patrick H. Maxwell, Désiré Collen, Mieke Dewerchin, Rakesh K. Jain, Karl H. Plate, Peter Carmeliet - Cancer Cell 2005 cited by 183